Allergen, Individual-Tree pollen Alder Alnus Incana T2

The Allergen, Individual-Tree pollen Alder (Alnus incana) T2 test is a targeted home-compatible blood test that measures allergen-specific IgE antibodies to Alnus incana pollen. A small blood sample is analyzed by a quantitative immunoassay to determine whether the immune system has developed sensitization to alder pollen, enabling an objective diagnosis of pollen-driven allergic disease. Accurate identification of alder sensitization is important for differentiating pollen allergy from other causes of rhinitis, conjunctivitis, or seasonal asthma and for guiding clinicians on avoidance strategies and treatment choices.

This test is particularly useful for residents of Dubai and the UAE who experience seasonal nasal, ocular, or respiratory symptoms that may coincide with tree-pollen exposure or landscaping activities. Results help clinicians and patients decide on targeted measures such as environmental control, pharmacotherapy, or allergen immunotherapy, and they can be used to monitor changes in sensitization over time. Results are provided in a quantitative format suitable for discussion with your treating physician or allergy specialist in the UAE healthcare system.

• Alnus incana (Alder) specific IgE (kU/L)
• IgE concentration (quantitative)
• Sensitization category / Result interpretation (Negative, Low, Moderate, High)
• Assay method (quantitative immunoassay)

• Seasonal sneezing, nasal congestion, or itchy/watery eyes during tree‑pollen season
• Worsening asthma or wheeze that correlates with outdoor tree exposure
• Before initiating allergen immunotherapy to confirm relevant sensitization
• Unexplained allergic symptoms after exposure to parks, landscaping, or imported trees
• When evaluating multi‑allergen sensitization in adults or children living in the UAE

• Precise identification of sensitization to alder (Alnus incana) pollen
• Enables personalised avoidance and environmental control recommendations
• Supports clinical decision‑making for immunotherapy or targeted treatment
• Convenient home sample collection with testing at an accredited laboratory
• Quantitative report suitable for review by your Dubai/UAE healthcare provider

• At‑home blood sample collection (finger‑prick kit or phlebotomist visit, per service option)
• No fasting required prior to sample collection
• Inform the provider about recent allergen immunotherapy or anti‑IgE biologic treatments
• Available for Dubai and wider UAE residents; sample couriered to an accredited lab for analysis